Firms

AN Venture Partners

AN Venture Partners

an.vc

Invests in and helps create biotechnology companies that bring Japanese scientific discoveries to global markets. Based in Tokyo and San Francisco, the firm connects Japanese academic and pharmaceutical research with the US startup ecosystem and finances companies from pre-seed through advanced clinical development across therapeutic modalities and disease areas, including neuroscience.

Founded
2022
Type
Venture capital

Funds1

  • AN Venture Partners I, LP$200M

    Final close in June 2025, announced July 2, 2025. A ten-year biotechnology fund launched in December 2023, investing from pre-seed to advanced clinical stages with a focus on Japanese science and global startups using Japanese technology.

Team

Vicki Sato
Vicki Sato

AN Venture Partners, Advisory Board Member

$25M$50K – $150MCambridge, Massachusetts
Ari Nowacek
$25M$50K – $150MSeattle, Washington
—— – —
—— – —
—— – —
—— – —
—— – —

Operations and support

Dai HataAssociate
Hiromitsu NakauchiAdvisory Board Member
Masaki TanakaInvestment Manager
Mikael DolstenAdvisory Board Member
Mike HickeyCFO
Natsuko KayashimaExecutive Assistant
Nick BayhiFellow
Olivia LaxtonAssociate
Paul RothmanAdvisory Board Member
Paula SchultheissSenior Associate
Shiho HiroseAnalyst
Wendy HungFellow
Yasuhiro YamadaAdvisory Board Member
Yumiko NejoController

Co-investing

Investments